We have located links that may give you full text access.
Journal Article
Research Support, Non-U.S. Gov't
Potential prognostic value of repulsive guidance molecules in breast cancer.
Anticancer Research 2011 May
BACKGROUND: Repulsive guidance molecules (RGMs) are novel co-receptors of bone morphogenetic proteins (BMPs) which have been implicated in bone metastasis of cancer. This study aimed to investigate roles played by RGMs in breast cancer.
MATERIALS AND METHODS: Expression of RGMs was examined in breast cancer cell lines using RT-PCR. The expression of RGMs in human breast cancer tissues was assessed using both quantitative PCR and immunohistochemical staining.
RESULTS: RGMB was detectable in both cell lines and tissues samples of breast cancer. RGMA and RGMC were expressed in the breast tissues, but were undetectable in the examined breast cancer cell lines. Furthermore, reduced expression of RGMA in breast cancer was associated with poor prognosis. RGMB transcript levels appeared to be lower in breast cancer with local recurrence and distant metastasis, but were relatively higher in the patients who died from the disease.
CONCLUSION: Aberrant expression of RGMs was indicated in breast cancer. The perturbed expression was associated with disease progression and poor prognosis.
MATERIALS AND METHODS: Expression of RGMs was examined in breast cancer cell lines using RT-PCR. The expression of RGMs in human breast cancer tissues was assessed using both quantitative PCR and immunohistochemical staining.
RESULTS: RGMB was detectable in both cell lines and tissues samples of breast cancer. RGMA and RGMC were expressed in the breast tissues, but were undetectable in the examined breast cancer cell lines. Furthermore, reduced expression of RGMA in breast cancer was associated with poor prognosis. RGMB transcript levels appeared to be lower in breast cancer with local recurrence and distant metastasis, but were relatively higher in the patients who died from the disease.
CONCLUSION: Aberrant expression of RGMs was indicated in breast cancer. The perturbed expression was associated with disease progression and poor prognosis.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app